Trump’s much-hyped $765 million plan to turn Eastman Kodak Company into pharmaceutical maker put on hold after concerns over insider trading. CoronavirusThe EconomyCorruption Oct 25 Written By 1,000 Hours of Outrage Cookout by Ryan FerlandInstagram: @ferland_inkSource: ForbesOutrage 768 of 1000 1,000 Hours of Outrage
Trump’s much-hyped $765 million plan to turn Eastman Kodak Company into pharmaceutical maker put on hold after concerns over insider trading. CoronavirusThe EconomyCorruption Oct 25 Written By 1,000 Hours of Outrage Cookout by Ryan FerlandInstagram: @ferland_inkSource: ForbesOutrage 768 of 1000 1,000 Hours of Outrage